Imax Corp (IMAX)
Official siteCOMMUNICATION SERVICES • ENTERTAINMENT • NYSE
Market Cap: $2.58B
Last updated: Nov 17, 2026 at 4:26 PM ET
Imax Corp (IMAX) Stock Chart
IMAX has a latest price of $47.10 on Nov 17, 2026, 18.4% below its 52-week high of $57.73. Its price rose 34.6% over the past 12 months. The month-end price rose 67.3% over the 10 years through Oct 2026, a compound annual rate of 5.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $54.80 in Sep 2026 and its lowest $9.05 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IMAX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMAX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 12.3%, and over 6 months it rose 42.3%. The month-end price rose 177.9% over the 3 years through Oct 2026, a compound annual rate of 40.6%.
| Period | Change |
|---|---|
| 1 month | -8.8% |
| 3 months | -12.3% |
| 6 months | +42.3% |
| 12 months | +34.6% |
| 12 months, with dividends | +34.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +177.9% | +40.6% |
| 5 years | +168.5% | +21.8% |
| 10 years | +67.3% | +5.3% |
Price by Year
Its best calendar year was 2024, when the price rose 70.4%, and its weakest was 2017, when it fell 26.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $50.61 | +36.9% |
| 2025 | $36.96 | +44.4% |
| 2024 | $25.60 | +70.4% |
| 2023 | $15.02 | +2.5% |
| 2022 | $14.66 | -17.8% |
| 2021 | $17.84 | -1.0% |
| 2020 | $18.02 | -11.8% |
| 2019 | $20.43 | +8.6% |
| 2018 | $18.81 | -18.7% |
| 2017 | $23.15 | -26.3% |
Trading Range
The price is 8.8% below its 50-day average of $51.62 and 7.9% above its 200-day average of $43.67.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $47.10 | |
| 52-week high | $57.73 | -18.4% |
| 52-week low | $32.71 | +44.0% |
| 50-day average | $51.62 | -8.8% |
| 200-day average | $43.67 | +7.9% |
Price Risk
Over 3 years, its largest fall from a peak was 22.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.35 |
| Largest fall, 1 year | -22.7% |
| Largest fall, 3 years | -22.7% |
Valuation
IMAX traded at 25.7x earnings at the end of 2025, against a 5-year median of 27.7x and a 10-year median of 26.9x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IMAX
What is IMAX's 1-year price change?
IMAX's price rose 34.6% over the past 12 months. With dividends included, the 12-month total return was 34.6%.
What is IMAX's 5-year price change?
IMAX's month-end price rose 168.5% over the 5 years through Oct 2026, a compound annual rate of 21.8%. These figures leave out dividends.
What is IMAX's 52-week high and low?
IMAX's 52-week high is $57.73 and its 52-week low is $32.71. Its latest price of $47.10 on Nov 17, 2026 is 18.4% below the high.
What is IMAX's beta?
IMAX's 1-year beta against the S&P 500 is 0.35, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 22.7%.
Is the IMAX chart free?
Yes. Advanced Charting for IMAX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IMAX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors